Industry updates with Dusko Ilic: June 2022

Read highlights from the latest installment of Dusko Ilic’s industry news, which discuss the latest developments and news in regenerative medicine and stem cell research, and are published every month in Regenerative Medicine. Every month, Dusko comments on regenerative medicine industry news of note. Read the full update for June 2022 in Regenerative Medicine here >>> Find previous updates here>> What happened this month that you were expecting? Smooth sailing for bluebird and Bristol Myers Squibb Unsurprisingly, the US FDA Cellular, Tissue and Gene Therapies Advisory Committee’s discussion of bluebird bio's (MA, USA) two cell therapies was short and sweet. The...